This paper is only available as a PDF. To read, Please Download here. ABSTRACT Background Systemic treatment with chemotherapy is warranted for patients with extensive-stage small cell lung cancer (ES-SCLC). The objective of this study was to determine if racial and other healthcare disparities exist in receipt of chemotherapy for ES-SCLC. Methods Utilizing the National Cancer Data Base, 148,961 patients diagnosed with stage IV SCLC from 2004-2016 were identified.
